Search by Drug Name or NDC

    NDC 00071-1012-68 Lyrica 25 mg/1 Details

    Lyrica 25 mg/1

    Lyrica is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Parke-Davis Div of Pfizer Inc. The primary component is PREGABALIN.

    Product Information

    NDC 00071-1012
    Product ID 0071-1012_a0943da6-ba39-48b7-a89c-ec2942f6d0af
    Associated GPIs 72600057000110
    GCN Sequence Number 057799
    GCN Sequence Number Description pregabalin CAPSULE 25 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 23039
    HICL Sequence Number 026470
    HICL Sequence Number Description PREGABALIN
    Brand/Generic Brand
    Proprietary Name Lyrica
    Proprietary Name Suffix n/a
    Non-Proprietary Name PREGABALIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name PREGABALIN
    Labeler Name Parke-Davis Div of Pfizer Inc
    Pharmaceutical Class n/a
    DEA Schedule CV
    Marketing Category NDA
    Application Number NDA021446
    Listing Certified Through 2024-12-31

    Package

    NDC 00071-1012-68 (00071101268)

    NDC Package Code 0071-1012-68
    Billing NDC 00071101268
    Package 90 CAPSULE in 1 BOTTLE (0071-1012-68)
    Marketing Start Date 2004-12-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 8.23
    Pricing Unit EA
    Effective Date 2021-01-01
    NDC Description LYRICA 25 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2022-01-12
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis